PPARA and hepatocellular carcinoma: Metabolic pathways consisting of “Fatty acid biosynthesis”, “Fatty acid degradation”, “Fatty acid metabolism”, “PPAR signaling pathway”, and “Biosynthesis of unsaturated fatty acids” significantly enriched in the low–risk group of the TCGA HBV–related HCC cohort (Fig. 4).